PLUS THERAPEUTICS, INC. - Common Stock, $0.001 par value per share (PSTV)

CUSIP: 72941H509

Q4 2024 13F Holders as of 31 Dec 2024

Type / Class
Equity / Common Stock, $0.001 par value per share
Shares outstanding
179,252,507
Total 13F shares
678,173
Share change
+6,523
Total reported value
$779,897
Price per share
$1.15
Number of holders
10
Value change
+$3,467
Number of buys
3
Number of sells
2

Quarterly Holders Quick Answers

What is CUSIP 72941H509?
CUSIP 72941H509 identifies PSTV - PLUS THERAPEUTICS, INC. - Common Stock, $0.001 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of PLUS THERAPEUTICS, INC. - Common Stock, $0.001 par value per share (PSTV) as of Q4 2024

As of 31 Dec 2024, PLUS THERAPEUTICS, INC. - Common Stock, $0.001 par value per share (PSTV) was held by 10 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 678,173 shares. The largest 10 holders included AIGH Capital Management LLC, GEODE CAPITAL MANAGEMENT, LLC, VANGUARD GROUP INC, TWO SIGMA SECURITIES, LLC, BlackRock, Inc., Tower Research Capital LLC (TRC), OSAIC HOLDINGS, INC., SBI Securities Co., Ltd., BANK OF AMERICA CORP /DE/, and DANSKE BANK A/S. This page lists 11 institutional shareholders reporting positions in this security for the Q4 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.